Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya - Full Text View

Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya

This study has been completed.

Sponsored by:	DBL -Institute for Health Research and Development
Information provided by:	DBL -Institute for Health Research and Development
ClinicalTrials.gov Identifier:	NCT00463307

Purpose

The purpose of this study is to evaluate the use of a urine test strip in diagnose schistosoma mansoni in areas of Kenya where the rate of infections are low.

The hypothesis is that the urine strip test is a superior tool to the conventional parasitological tools used to diagnose schistosomiasis mansoni infections in area where there is low transmission

Condition

Schistosomiasis Mansoni
Circulating Cathodic Antigen Urine Based Dipstick

U.S. FDA Resources

Study Type:	Observational
Study Design:	Other

Official Title:	Evaluation of Applicability of Urine Based Schistosomiasis Test Strip in the Epidemiologic Mapping and Sampling of Schistosoma Mansoni Infection in Low Endemic Areas of Kenya

Further study details as provided by DBL -Institute for Health Research and Development:

Enrollment:	1100
Study Start Date:	April 2006
Study Completion Date:	November 2006

Detailed Description:

The study will compare the use of the urine test strip with the conventional method used and with a "golden standard" methode, in an area of Kenya where the infection transmission is low. Furthermore will the urine test strip be evaluatied in its ability to monitor the intensity of infections in school children before and after they are been treated for the infections.

A total of 1100 school children in the age between 10 and 18 years will be included in the study. Children have to submitt a stool and a urine sample on three consecutive days. Children who are found to be infected with the schistosomiasis parasite will be offered treatment.

Eligibility

Ages Eligible for Study:	10 Years to 18 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Children in the age between 10 and 18 years

Exclusion Criteria:

Children younger then 10 years of age and children whos parent/guardians did not give informed consents for their participation in the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00463307

Locations


Kenya
	Kenya Medical Research Institute
	Nairobi, Kenya

Sponsors and Collaborators

DBL -Institute for Health Research and Development

Investigators


Principal Investigator:	Hussein J Kihara, mr	Division of Vector Borne Diseases, Kenya

More Information

Study ID Numbers:	SRP-KY-JK-06
First Received:	April 19, 2007
Last Updated:	October 30, 2007
ClinicalTrials.gov Identifier:	NCT00463307
Health Authority:	Kenya: Institutional Review Board

Keywords provided by DBL -Institute for Health Research and Development:

schistosomiasis

Schistosoma mansoni

Circulating cathodic antigen urine dipstick

Study placed in the following topic categories:

Schistosomiasis mansoni

Schistosomiasis

Parasitic Diseases

Helminthiasis

Additional relevant MeSH terms:

Trematode Infections

Infection

ClinicalTrials.gov processed this record on September 04, 2008